# Yousen Jianheng Biomedical (Shanghai) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yousen-jianheng-biomedical-shanghai-co

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Total disclosed funding: $31M
- Latest round: Series A (Feb 8, 2022)
- Investors on record: 3

## About

Established in 2020 and based in Shanghai, China, Yousen Jianheng Biomedical (Shanghai) Co., Ltd. operates as a medicine manufacturer that focuses on First-in-class/Best-in-class medicine development. In February 2022, the company raised over CNY 200 million in series A funding.

The medicines of the company can be used for cancer and autoimmune diseases. The research and development includes small molecule targeted drugs, recombinant proteins and single/dual antibody drugs. The company's UA007 program is in clinical phase II (prevention and treatment of cardiovascular disease) and clinical phase I (treatment of acute gout).

The company plans to accelerate the clinical trials of UA007 and UA021 and development of small molecule drugs with multiple new targets and development of specific dual antibodies.

## Funding rounds

- Series A, Feb 8, 2022, $31M — Share Capital, Yingke Private Equity, Zhangjiang Haoheng Capital

## Investors

- Share Capital (https://capitalatlas.ai/funds/share-capital) — Series A
- Yingke Private Equity (https://capitalatlas.ai/funds/yingke-private-equity) — Series A
- Zhangjiang Haoheng Capital (https://capitalatlas.ai/funds/zhangjiang-haoheng-capital) — Series A